Abstract #1139
Preliminary evidence of a vascular normalization biomarker in trastuzumab-treated HER2+ breast cancer
Anna G. Sorace 1,2 , Jennifer G. Whisenant 1,2 , J. Oliver McIntyre 2,3 , Violeta M. Sanchez 4 , Mary E. Loveless 2 , and Thomas E. Yankeelov 1,2
1
Radiology, Vanderbilt University, Nashville,
Tennessee, United States,
2
Vanderbilt
University Institute of Imaging Science, Vanderbilt
University, Nashville, Tennessee, United States,
3
Cancer
Biology, Vanderbilt University, Nashville, Tennessee,
United States,
4
Hematology
Oncology, Vanderbilt University, Nashville, Tennessee,
United States
We use quantitative DCE-MRI to determine sensitivity to
HER2+ targeted breast cancer treatments early in the
course of therapy. Preclinical studies utilizing mice
with HER2+ (sensitive or resistant) tumors were treated
with trastuzumab or saline. DCE-MRI was longitudinally
tracked from baseline to day 4. DCE-MRI parameter,
K
trans
,
revealed significant increases post treatment in the
HER2+ sensitive, treated tumors compared to their
control counterparts, untreated and HER2+ resistant
treated, therefore suggesting vessel normalization.
Paralleled histological parameter, microvessel density,
also revealed significant increases. Imaging biomarkers
have potential as a noninvasive tool to discriminate
responders from nonresponders early during the course of
therapy.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Click here for more information on becoming a member.
